Open an account

Yield10 Bioscience

YTENQ · OTC

$0.00+$0.0001 (−100.00%)TodayMarket closed ·
No price history for this range.

About YTENQ

Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company is headquartered in Woburn, Massachusetts and currently employs 29 full-time employees. The company went IPO on 2006-11-10. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and PHA bioplastics for use as biodegradable bioplastics. The firm is pursuing Camelina seed oil products for two market opportunities and value chains. The first product is seed oil produced by Camelina, which is genetically engineered to enable production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). The second product is Camelina seed oil for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD) and sustainable aviation fuel (SAF).

Employees
29
Headquarters
Woburn, Massachusetts
Listed
Nov 10, 2006
Sector
Health Care
Industry
Biotechnology
Website
yield10bio.com

YTENQ key statistics

Market cap
1
Price-earnings ratio
-0.00
Dividend yield
—
Average volume
1.87K
Volume
18
Open price
$0.00
High today
$0.00
Low today
$0.00
52 Week high
$0.0002
52 Week low
$0.00

Yield10 Bioscience (YTENQ) at a glance

Yield10 Bioscience (YTENQ) last traded at $0.00, with a market cap of 1 and a price-to-earnings ratio of 0.00.

Volume so far is 18 shares, below the average of 1.87K shares a day.

Over the past year Yield10 Bioscience has ranged from $0.00 to $0.0002, and now sits -1% of the way up that range.

Yield10 Bioscience met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q2 FY24 it reported -$5.04 per share against an estimate of -$4.08.

YTENQ earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 8 quarters, by 14.1% on average.

  1. Q3 FY22: reported -$17.04 per share against an estimate of -$16.07
  2. Q4 FY22: reported -$16.08 per share against an estimate of -$14.96
  3. Q1 FY23: reported -$18.24 per share against an estimate of -$15.66
  4. Q2 FY23: reported -$15.36 per share against an estimate of -$13.43
  5. Q3 FY23: reported -$9.84 per share against an estimate of -$9.72
  6. Q4 FY23: reported -$6.48 per share against an estimate of -$7.54
  7. Q1 FY24: reported -$4.77 per share against an estimate of -$2.72
  8. Q2 FY24: reported -$5.04 per share against an estimate of -$4.08

Similar companies

Companies in the same industry as Yield10 Bioscience

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.